Home » Topics » Conferences

Conferences
RSS

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

Yamanouchi selects YM-471 for clinical development

April 19, 1996

New ETA antagonist from SmithKline Beecham: SB-225757

April 19, 1996

EMD-94246, promising endothelin antagonist for hypertension

April 19, 1996

CMI-568, dual PAF antagonist and 5-LO inhibitor from CytoMed

April 19, 1996

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

Nerve growth synthesis inducers produce neuroprotective effects

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 22, 2025.
Biopharma restructurings reflect strategy of short-term pain for long-term gains
BioWorld
Ongoing restructurings in the biopharma sector show common themes of cost-cutting, clinical failures and shifting strategic priorities. Companies are increasingly...
Field Medical harvests $40M for PFA system
BioWorld MedTech
Field Medical Inc. reaped $40 million in its series A fundraising via $20 million in new capital and conversion of $20 million in seed-round debt to support...
Roche follows other pharmas, committing $50B in US investment
BioWorld
Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug...